The cytoskeleton—a complex interacting meshwork

T Hohmann, F Dehghani - Cells, 2019 - mdpi.com
The cytoskeleton of animal cells is one of the most complicated and functionally versatile
structures, involved in processes such as endocytosis, cell division, intra-cellular transport …

Diffuse glioma growth: a guerilla war

A Claes, AJ Idema, P Wesseling - Acta neuropathologica, 2007 - Springer
In contrast to almost all other brain tumors, diffuse gliomas infiltrate extensively in the
neuropil. This growth pattern is a major factor in therapeutic failure. Diffuse infiltrative glioma …

The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting

JA Winkles - Nature reviews Drug discovery, 2008 - nature.com
TWEAK is a multifunctional cytokine that controls many cellular activities including
proliferation, migration, differentiation, apoptosis, angiogenesis and inflammation. TWEAK …

Recent progress of nanocarrier-based therapy for solid malignancies

QY Wei, YM Xu, ATY Lau - Cancers, 2020 - mdpi.com
Simple Summary Although conventional anti-cancer drugs have been the footstone in the
fight against cancer, yet they are far from optimal due to issues related with indiscriminate …

TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease

LC Burkly, JS Michaelson, K Hahm, A Jakubowski… - Cytokine, 2007 - Elsevier
First described as a weak apoptosis inducer, the TNF superfamily ligand TWEAK has since
emerged as a cytokine that regulates multiple cellular responses, including proinflammatory …

Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-κB, and glucose regulation

S Kotliarova, S Pastorino, LC Kovell, Y Kotliarov… - Cancer research, 2008 - AACR
Abstract Glycogen synthase kinase 3 (GSK3), a serine/threonine kinase, is involved in
diverse cellular processes ranging from nutrient and energy homeostasis to proliferation and …

TWEAK/Fn14 signaling in tumors

G Hu, W Zeng, Y Xia - Tumor Biology, 2017 - journals.sagepub.com
TWEAK (tumor necrosis factor–related weak inducer of apoptosis), a member of the tumor
necrosis factor superfamily, acts on cells by binding to its only receptor named Fn14 …

An experimenter's guide to glioblastoma invasion pathways

MC de Gooijer, MG Navarro, R Bernards… - Trends in molecular …, 2018 - cell.com
Glioblastoma is a highly aggressive brain tumor that is characterized by its unparalleled
invasiveness. Invasive glioblastoma cells not only escape surgery and focal therapies but …

Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy

KE Cahill, RA Morshed, B Yamini - Neuro-oncology, 2015 - academic.oup.com
Nuclear factor-κB (NF-κB) is a ubiquitous transcription factor that regulates multiple aspects
of cancer formation, growth, and treatment response. Glioblastoma (GBM), the most common …

A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications

LC Bover, M Cardó-Vila, A Kuniyasu, J Sun… - The Journal of …, 2007 - journals.aai.org
TWEAK (TNF-like weak inducer of apoptosis) is a TNF superfamily member implicated in
several mechanisms. Although fibroblast growth factor inducible 14 (Fn14)/TweakR has …